HomeCompareULIHF vs SBUX

ULIHF vs SBUX: Dividend Comparison 2026

ULIHF yields 4.61% · SBUX yields 2.84%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 ULIHF wins by $3914.21M in total portfolio value
10 years
ULIHF
ULIHF
● Live price
4.61%
Share price
$1.30
Annual div
$0.06
5Y div CAGR
100%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$3914.38M
Annual income
$3,757,849,931.79
Full ULIHF calculator →
SBUX
SBUX
● Live price
2.84%
Share price
$86.72
Annual div
$2.46
5Y div CAGR
48.3%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$167.0K
Annual income
$71,136.45
Full SBUX calculator →

Portfolio growth — ULIHF vs SBUX

📍 ULIHF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodULIHFSBUX
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, ULIHF + SBUX cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
ULIHF pays
SBUX pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ULIHF
Annual income on $10K today (after 15% tax)
$392.01/yr
After 10yr DRIP, annual income (after tax)
$3,194,172,442.02/yr
SBUX
Annual income on $10K today (after 15% tax)
$241.12/yr
After 10yr DRIP, annual income (after tax)
$60,465.98/yr
At 15% tax rate, ULIHF beats the other by $3,194,111,976.04/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ULIHF + SBUX for your $10,000?

ULIHF: 50%SBUX: 50%
100% SBUX50/50100% ULIHF
Portfolio after 10yr
$1957.27M
Annual income
$1,878,960,534.13/yr
Blended yield
96.00%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on SBUX right now

ULIHF
No analyst data
Altman Z
2.5
Piotroski
3/9
SBUX
Analyst Ratings
28
Buy
27
Hold
3
Sell
Consensus: Buy
Price Target
$104.00
+19.9% upside vs current
Range: $90.00 — $120.00
Altman Z
2.6
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ULIHF buys
0
SBUX buys
0
No recent congressional trades found for ULIHF or SBUX in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricULIHFSBUX
Forward yield4.61%2.84%
Annual dividend / share$0.06$2.46
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR100%48.3%
Portfolio after 10y$3914.38M$167.0K
Annual income after 10y$3,757,849,931.79$71,136.45
Total dividends collected$3903.33M$136.4K
Payment frequencyquarterlyquarterly
SectorStockConsumer Discretionary

Year-by-year: ULIHF vs SBUX ($10,000, DRIP)

YearULIHF PortfolioULIHF Income/yrSBUX PortfolioSBUX Income/yrGap
1← crossover$11,622$922.37$11,121$420.68+$501.00ULIHF
2$14,440$2,003.76$12,548$648.40+$1.9KULIHF
3$20,104$4,653.23$14,440$1,013.98+$5.7KULIHF
4$33,620$12,109.28$17,068$1,617.30+$16.6KULIHF
5$73,826$37,852.07$20,912$2,649.52+$52.9KULIHF
6$234,355$155,361.26$26,875$4,499.29+$207.5KULIHF
7$1,172,599$921,838.97$36,771$8,014.12+$1.14MULIHF
8$9,876,061$8,621,381.00$54,542$15,197.11+$9.82MULIHF
9$146,291,644$135,724,258.55$89,602$31,242.49+$146.20MULIHF
10$3,914,381,991$3,757,849,931.79$167,011$71,136.45+$3914.21MULIHF

ULIHF vs SBUX: Complete Analysis 2026

ULIHFStock

The United Laboratories International Holdings Limited, an investment holding company, engages in the research, development, manufacture, distribution, and sale of pharmaceutical products. It operates through three segments: Bulk Medicine, Intermediate Products, and Finished Products. The company offers oral antibiotics, antimicrobials for injection, anti-cold products, cough medicines, ophthalmic drugs, antiviral drugs, anti-hepatitis B drugs, diabetes drugs, skin drugs for external use, cardiovascular and cerebrovascular drugs, nervous system drugs, vitamins, and vacant gelatin capsules, as well as API and intermediate products. It also manufactures and sells soft capsules casings; holds trademarks; and trades in pharmaceutical products. In addition, the company provides management services. It has operations in the People's Republic of China, Europe, India, the Middle East, South America, other Asian regions, and internationally. The company was founded in 1990 and is headquartered in Yuen Long, Hong Kong.

Full ULIHF Calculator →

SBUXConsumer Discretionary

Starbucks Corporation, together with its subsidiaries, operates as a roaster, marketer, and retailer of specialty coffee worldwide. The company operates through three segments: North America, International, and Channel Development. Its stores offer coffee and tea beverages, roasted whole beans and ground coffees, single serve products, and ready-to-drink beverages; and various food products, such as pastries, breakfast sandwiches, and lunch items. The company also licenses its trademarks through licensed stores, and grocery and foodservice accounts. The company offers its products under the Starbucks, Teavana, Seattle's Best Coffee, Evolution Fresh, Ethos, Starbucks Reserve, and Princi brands. As of October 3, 2021, it operated 16,826 company-operated and licensed stores in North America; and 17,007 company-operated and licensed stores internationally. The company was founded in 1971 and is based in Seattle, Washington.

Full SBUX Calculator →
📬

Get this ULIHF vs SBUX comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ULIHF vs SCHDULIHF vs JEPIULIHF vs OULIHF vs KOULIHF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.